Central Nervous System: Clinical Trials

3 trials for Central Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow Central Nervous System: new trials by email Literature Review of Central Nervous System trials Research Report on Central Nervous System

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Alectinib - Neoplasms, Colorectal Neoplasms
Phase 2TerminatedHoffmann-La Roche12021-05-242023-08-07
Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)
Doravirine, Tenofovir, Lamivudine - Blinded, Doravirine, Tenofovir, Lamivudine - Open-Label, ATRIPLA^TM - HIV-1, Central Nervous System
Phase 2CompletedMerck Sharp & Dohme LLC862016-03-042025-02-07
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
perampanel - Central Nervous System
Phase 2CompletedEisai Inc.632012-01-012016-07-12

Narrower conditions

Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Renal Cell (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Adenocarcinoma, Papillary (1)  ·  Adnexal Diseases (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

Lamivudine (1)  ·  Tenofovir (1)  ·  alectinib (1)  ·  doravirine (1)  ·  perampanel (1)

Sponsors

Eisai Inc. (1)  ·  Hoffmann-La Roche (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (2)

Top investigators

Michelle Gee (1)

Results publications

PMID 30739576, PMID 33587439

NIH funding

2015 (1)